Provisions and Special Considerations for Rare Diseases / Orphan Drugs by Health Technology Assessment (HTA) Bodies: Systematic Evaluation in 25 Countries

Autor:	Ramesh, Mkaya Mwamburi, S Gala, M Nanavaty, A Nyandege
Rok vydání:	2016
Předmět:	Orphan drug medicine.medical_specialty business.industry Health Policy Environmental health Family medicine Public Health Environmental and Occupational Health Alternative medicine Health technology Medicine business
Zdroj:	Value in Health. 19:A602
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b657d75749422f804af3924630066d97 https://doi.org/10.1016/j.jval.2016.09.1471 Zobrazit plný text záznamu Full Text from ScienceDirect